Urinary tract infections in obstetrics and gynecology: current issues of diagnosis and antibiotic therapy

Cover Page


Cite item

Full Text

Abstract

Urinary tract infections are among the most common infectious diseases in women and often complicate the course of pregnancy. This article reviews current scientific and methodical literature on the management of pregnant women with urinary tract infection. Aspects of clinical importance of urinary tract infections during pregnancy (epidemiology, clinical manifestations, and complications) are discussed, with current recommendations for diagnosis and management of urinary tract infections summarized. Special attention is paid to the problem of antibiotic resistance of urinary tract infection pathogens.

About the authors

Tatyana A. Khusnutdinova

The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott; Saint Petersburg State Pediatric Medical University

Author for correspondence.
Email: HusnutdinovaT@yandex.ru

Researcher. The Laboratory of Microbiology; Assistant. The Department of Clinical Laboratory Diagnostics, the Faculty of Postgraduate and Additional Professional Education

Russian Federation, Saint Petersburg

References

  1. Bacak SJ, Callaghan WM, Dietz PM, Crouse C. Pregnancy-associated hospitalizations in the United States, 1999-2000. Am J Obstet Gynecol. 2005;192(2):592-597. https://doi.org/10.1016/j.ajog.2004.10.638.
  2. Yan L, Jin Y, Hang H, Yan B. The association between urinary tract infection during pregnancy and preeclampsia: A meta-analysis. Medicine (Baltimore). 2018;97(36):e12192. https://doi.org/10.1097/MD.0000000000012192.
  3. Glaser AP, Schaeffer AJ. Urinary tract infection and bacteriuria in pregnancy. Urol Clin North Am. 2015;42(4):547-560. https://doi.org/10.1016/j.ucl.2015.05.004.
  4. Bonkat G, Pickard R, Bartoletti R, et al. Guidelines Associates: Cai T, Köves B, Pilatz A, Pradere B, Veeratterapillay R. EAU guidelines on Urological Infections. European Association of Urology; 2017.
  5. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. – М., 2017 [Perepanova TS, Kozlov RS, Rudnov VA, Sinyakova LA. Antimikrobnaya terapiya i profilaktika infektsiy pochek, mochevyvodyashchikh putey i muzhskikh polovykh organov. Federal’nye klinicheskie rekomendatsii. Мoscow; 2017. (In Russ.)]
  6. Matuszkiewicz-Rowinska J, Malyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015;11(1):67-77. https://doi.org/10.5114/aoms. 2013.39202.
  7. Ipe DS, Sundac L, Benjamin WH, Jr., et al. Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiol Lett. 2013;346(1):1-10. https://doi.org/10.1111/1574-6968.12204.
  8. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2015(8):CD000490. https://doi.org/10.1002/14651858.CD000490.pub3.
  9. Perez-Moreno MO, Pico-Plana E, Grande-Armas J, et al. Group B streptococcal bacteriuria during pregnancy as a risk factor for maternal intrapartum colonization: a prospective cohort study. J Med Microbiol. 2017;66(4):454-460. https://doi.org/10.1099/jmm.0.000465.
  10. Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease – revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
  11. Wingert A, Pillay J, Sebastianski M, et al. Asymptomatic bacteriuria in pregnancy: systematic reviews of screening and treatment effectiveness and patient preferences. BMJ Open. 2019;9(3):e021347. https://doi.org/10.1136/bmjopen-2017-021347.
  12. Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008;38 Suppl 2:50-57. https://doi.org/10.1111/j.1365-2362.2008.02009.x.
  13. Kazemier BM, Koningstein FN, Schneeberger C, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015;15(11):1324-1333. https://doi.org/10.1016/s1473-3099(15)00070-5.
  14. Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol. 2014;210(3):219;e211-216. https://doi.org/ 10.1016/j.ajog.2013.10.006.
  15. Farkash E, Weintraub AY, Sergienko R, et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):24-27. https://doi.org/10.1016/j.ejogrb.2012.01.024.
  16. Schneeberger C, Geerlings SE, Middleton P, Crowther CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev. 2015(7):CD009279. https://doi.org/10.1002/14651858.CD009279.pub3.
  17. Sobel JD, Kaye D. Urinary tract infections. In: Principles and Practice of Infectious Disease. Ed. by J.E. Bennett, R. Dolin, M.J. Blaser. Vol. 1. Philadelphia: Churchill Livingstone Elsevier; 2014. P. 886-914.
  18. Lumbiganon P, Laopaiboon M, Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol. 2010;22(2):95-99. https://doi.org/10.1097/GCO.0b013e3283374adf.
  19. Lin K, Fajardo K, Force USPST. Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008;149(1):W20-24. https://doi.org/10.7326/0003-4819-149-1-200807010- 00009-w1.
  20. Glaser AP, Schaeffer AJ. Urinary tract infection and bacteriuria in pregnancy. Urol Clin North Am. 2015;42(4):547-560. https://doi.org/10.1016/j.ucl.2015.05.004.
  21. van der Zee A, Roorda L, Bosman G, Ossewaarde JM. Molecular diagnosis of urinary tract infections by semi-quantitative detection of uropathogens in a routine clinical hospital setting. PLoS One. 2016;11(3):e0150755. https://doi.org/10.1371/journal.pone.0150755.
  22. Tse H, Hansen WLJ, van der Donk CFM, et al. A real-time PCR-based semi-quantitative breakpoint to aid in molecular identification of urinary tract infections. PLoS One. 2013;8(4):e61439. https://doi.org/10.1371/journal.pone.0061439.
  23. Хуснутдинова Т.А., Шипицына Е.В., Савочкина Ю.А., и др. Определение значимой бактериурии у беременных женщин методом количественной ПЦР в реальном времени // Журнал акушерства и женских болезней. – 2016. – Т. 65. – № 4. – C. 50–56. [Khusnutdinova TA, Shipitsyna EV, Savochkina YA, et al. Evaluation of significant bacteriuria in pregnant women using quantitative real-time PCR. Journal of Obstetrics and Women’s Diseases. 2016;65(4):50-56. (In Russ.)]. https://doi.org/10.17816/JOWD65450-56.
  24. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-284. https://doi.org/10.1038/nrmicro3432.
  25. Widmer M, Lopez I, Gulmezoglu AM, et al. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev. 2015(11):CD000491. https://doi.org/10.1002/14651858.CD000491.pub3.
  26. Vazquez JC, Abalos E. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev. 2011(1):CD002256. https://doi.org/10.1002/14651858.CD002256.pub2.
  27. Guinto VT, De Guia B, Festin MR, Dowswell T. Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2010(9):CD007855. https://doi.org/10.1002/14651858.CD007855.pub2.
  28. Gupta V, Nag D, Garg P. Recurrent urinary tract infections in women: How promising is the use of probiotics? Indian J Med Microbiol. 2017;35(3):347. https://doi.org/10.4103/ijmm.IJMM_16_292.
  29. Chisholm AH. Probiotics in preventing recurrent urinary tract infections in women: A literature review. Urol Nurs. 2015;35(1):18-21.
  30. Magistro G, Stief CG. Vaccine development for urinary tract infections: Where do we stand? Eur Urol Focus. 2019;5(1):39-41. https://doi.org/10.1016/j.euf.2018. 07.034.
  31. Asadi Karam MR, Habibi M, Bouzari S. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against uropathogenic Escherichia coli. Mol Immunol. 2019;108:56-67. https://doi.org/10.1016/ j.molimm.2019.02.007.
  32. www.who.int [Internet]. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2016-2017 [cited 24 Oct 2019]. Available from: https://www.who.int/glass/resources/publications/early-implementation-report-supplementary-materials/en/.
  33. Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии. Клинические рекомендации. Определение чувствительности микроорганизмов к антимикробным препаратам. – М., 2015. [Mezhregional’naya assotsiatsiya po klinicheskoy mikrobiologii i antimikrobnoy khimioterapii. Klinicheskie rekomendatsii. Opredelenie chuvstvitel’nosti mikroorganizmov k antimikrobnym preparatam. Мoscow; 2015 (In Russ.)]
  34. Практическое руководство по антиинфекционной химиотерапии / под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. – Смоленск, 2007 [Prakticheskoe rukovodstvo po antiinfektsionnoy khimioterapii. Ed. by L.S. Strachunskiy, Y.B. Belousov, S.N. Kozlov. Smolensk; 2017. (In Russ.)]
  35. Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria. Annu Rev Microbiol. 2011;65:455-478. https://doi.org/10.1146/annurev-micro-090110-102911.
  36. Ny S, Edquist P, Dumpis U, et al. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia. J Glob Antimicrob Resist. 2019;17:25-34. https://doi.org/10.1016/j.jgar.2018.11.004.
  37. Палагин И.С., Сухорукова М.В., Дехнич А.В., и др. Современное состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевых путей в России: результаты исследования «ДАРМИС» (2010–2011) // Клиническая микробиология и антимикробная химиотерапия. – 2012. – Т. 14. – № 4. – С. 280–302. [Palagin IS, Sukhorukova MV, Dekhnich AV, et al. Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia: DARMIS Study (2010–2011). Clinical microbiology and antimicrobial chemotherapy. 2012;14(4):280-302. (In Russ.)]
  38. Rafalskiy V, Pushkar D, Yakovlev S, et al. Distribution and antibiotic resistance profile of key gram-negative bacteria that cause community-onset urinary tract infections in the Russian Federation: RESOURCE multicentre surveillance 2017 study. J Glob Antimicrob Resist. 2019. https://doi.org/10.1016/j.jgar.2019.09.008.
  39. Локшин К.Л., Ширшов В.Н., Попко А.С., и др. Современное состояние антибиотикорезистентности и состав возбудителей инфекций мочевыводящих путей у беременных // Вестник урологии. – 2018. – Т. 6. – № 2. – С. 13–20. [Lokshin KL, Shirshov VN, Popko AS, et al. The current state of antibiotic resistance and the composition of pathogens of urinary tract infections in pregnant women. Urology Herald. 2018;6(2):13-20. (In Russ.)]. https://doi.org/10.21886/2308-6424-2018-6-2- 13-20.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Khusnutdinova T.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies